SiNtx Technologies Inc (SINT)

[boston745]

Why is that patent so important and valuable for Sintx? First, it gives them a proprietary technique to enhance current biomaterials by giving them some of the benefits of Sintx Silicon Nitride. Sintx with this patent, in theory, could coat every major orthopedic implant out there in this 64+bn orthopedic market enhancing them with properties no other coating or material can provide. I have argued repeatedly that Sintx is sitting on billion dollar IP and I believe thats true for just the orthopedic applications for which this patent could play a large role. Particularly in helping the market better understand this material and gradually migrate to it.
Silicon Nitride should replace almost all metal components one day due to the negative consequences that metal implants impart on the end user as the earths magnetic field continues to weaken. We are talking reduced release of metal ions into blood/organs, reduced amplification of EM radiation cause various ailments in patents, and reduced risk of Hutchison Effect causing spontaneous fracturing of these implants requiring revision surgery, increased pain, and potential infection. All of which will only get worse with time as we are exposed to greater amounts of EM radiation.

The patent, expected to be issued soon, protects a revolutionary method for laser bonding bioactive silicon nitride to various biomedical implant substrates, including titanium, alumina, zirconia, and advanced polymers like PEKK. This breakthrough technology enhances the biological performance of these substrates by imparting silicon nitride’s superior osseointegration and bacterial resistance properties.

Secondly, the application method allows them to not only coat future implants with Si3N4, but all current inventory of those implants once FDA allowed that is.

These advancements not only open new opportunities in the biomedical field but also offer innovative pathways for upgrading existing devices with silicon nitride’s unmatched properties. Additionally, the coating method enables the refinishing of implants, enhancing their functionality and extending their usability—a significant advantage in today’s medical device market.

This is all information released in the December 17th PR that was absent in the Feb 19th PR. Also, and i just realized this, the patent that the heading of the Feb PR references, is actually referenced in the Dec PR. So they already "disclosed" that patent...barely. Thus reinforcing that what was done on the Feb PR was purposeful. Because I didnt catch this, i had been expecting news of this patent for months now...

The technology complements a recently granted U.S. Patent (US 12162807), expanding SINTX’s capabilities to enhance traditional implantable device materials.